1. Home
  2. TTEC vs EQ Comparison

TTEC vs EQ Comparison

Compare TTEC & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TTEC Holdings Inc.

TTEC

TTEC Holdings Inc.

HOLD

Current Price

$2.20

Market Cap

128.5M

Sector

Technology

ML Signal

HOLD

EQ

Equillium Inc.

HOLD

Current Price

$2.97

Market Cap

129.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TTEC
EQ
Founded
1982
2017
Country
United States
United States
Employees
69400
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.5M
129.0M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
TTEC
EQ
Price
$2.20
$2.97
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
N/A
$8.00
AVG Volume (30 Days)
779.4K
845.0K
Earning Date
05-07-2026
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
40.80
N/A
EPS
N/A
N/A
Revenue
$1,509,171,000.00
$41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.15
N/A
52 Week Low
$1.91
$0.29
52 Week High
$5.51
$3.54

Technical Indicators

Market Signals
Indicator
TTEC
EQ
Relative Strength Index (RSI) 44.18 52.86
Support Level $2.12 $1.68
Resistance Level $2.58 $3.15
Average True Range (ATR) 0.15 0.26
MACD 0.01 -0.01
Stochastic Oscillator 41.05 26.41

Price Performance

Historical Comparison
TTEC
EQ

About TTEC TTEC Holdings Inc.

TTEC Holdings Inc provides customer engagement management tools and services. The company operates through two operating segment, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its revenues are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: